A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Lymphoma Study Association
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Barbara Ann Karmanos Cancer Institute
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital